CLINICAL_TRIALS
trial_result
· 2021-09-08
Clinical Trial Update: Long Acting Insulin Versus Multiple Dose Regimen for Control of Gestational Diabetes Mellitus [Phase 2, Phase 3]
Summary
A phase 2/3 clinical trial comparing long-acting insulin to a multiple-dose regimen for managing gestational diabetes mellitus has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Ain Shams University | Conditions: Long Acting Insulin in Control of Gestational Diabetes Mellitus | Phase 2, Phase 3 | Status: COMPLETED